BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997
84780 results:

  • 1. Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC.
    Lu Y; Langerman SS; McCain E; Magee K; Maund SL; Srivastava MK; Samant M
    JAMA Netw Open; 2024 May; 7(5):e249286. PubMed ID: 38700864
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
    Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
    Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Structural Racism as a Contributor to lung cancer Incidence and Mortality Rates Among Black Populations in the United States.
    Robinson-Oghogho JN; Alcaraz KI; Thorpe RJ
    Cancer Control; 2024; 31():10732748241248363. PubMed ID: 38698674
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Radicality of mediastinal lymphadenectomy in minimally invasive pulmonary resection: a comparative analysis of uniportal and multiportal thoracoscopic approaches.
    Tulinský L; Kepičová M; Ihnát P; Mitták M; Adamica D; Čierna L; Martínek L
    Rozhl Chir; 2024; 103(2):48-56. PubMed ID: 38697813
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. lung cancer-specific symptoms and fear of cancer recurrence among recurrence-free non-small cell lung cancer survivors.
    Lee G; Ahn A; Lee D; Kim TE; Kong S; Kang D; Kim HK; Shim YM; Cho J
    Support Care Cancer; 2024 May; 32(5):322. PubMed ID: 38695959
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary lung cancer in children and adolescents.
    Chen Q; Cheng J; Wang L; Lv X; Hu J
    J Cancer Res Clin Oncol; 2024 May; 150(5):225. PubMed ID: 38695944
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Contrast-enhanced Imaging in Peripheral Pulmonary Lesions: The Role in US-guided Biopsies.
    Wang XY; Yuan ZF; Gan KH; Zhong Y; Huang JX; Huang WJ; Xie YH; Pei XQ
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230234. PubMed ID: 38695742
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis.
    Gong S; Li Q; Yu X; Yang S
    Front Immunol; 2024; 15():1362537. PubMed ID: 38694505
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
    Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
    Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Metastasis of small cell lung cancer to bilateral extraocular muscles: a case report.
    Ramalhão JP; Vieira BC; Rodrigues D; Afonso MG; Gouveia J; Baptista PM; Araújo M
    J Med Case Rep; 2024 May; 18(1):216. PubMed ID: 38693545
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Value of turbo spin echo-based diffusion-weighted imaging in the differential diagnosis of benign and malignant solitary pulmonary lesions.
    Lei Q; Liu L; Li J; Yu K; Yin Y; Wang J; Su S; Song Y; Jiang G
    Sci Rep; 2024 Apr; 14(1):9965. PubMed ID: 38693152
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Stem-like CD8 T cells in stage I lung adenocarcinoma as a prognostic biomarker: A preliminary study.
    Sang J; Liu P; Wang M; Xu F; Ma J; Wei Z; Ye X
    J Cancer Res Ther; 2024 Apr; 20(2):669-677. PubMed ID: 38687939
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.
    Huang S; Kang X; Wang C; Zhang W; Jiang J; Kang Z; Yang S; Chen J; Chen F; Li W
    J Cancer Res Ther; 2024 Apr; 20(2):658-664. PubMed ID: 38687937
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Microwave ablation combined with percutaneous vertebroplasty for treating painful non-small cell lung cancer with spinal metastases under real-time temperature monitoring.
    Wu L; Hu M; Li P; Man Q; Yuan Q; Zhang X; Qiu Y; Chen L; Fan J; Zhang K
    J Cancer Res Ther; 2024 Apr; 20(2):540-546. PubMed ID: 38687923
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.
    Zhang MS; Yeh YC; Huang HN; Lin LW; Huang YL; Wang LC; Yao LJ; Hung TC; Tseng YF; Lee YH; Liao WY; Shih JY; Hsieh MS
    PLoS One; 2024; 19(4):e0301120. PubMed ID: 38687753
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic outcomes of radial endobronchial ultrasound bronchoscopy guided by manual navigation in the evaluation of peripheral pulmonary lesions: An observational study.
    Yuan M; Hu Y; Wang L; Yin W; Xiao Y
    Clin Respir J; 2024 May; 18(5):e13768. PubMed ID: 38685753
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non-small cell lung cancer undergoing stereotactic body radiotherapy.
    Fang F; Jia Z; Xie H; Cao Y; Zhu X; Yang XY; Guo X; Zhang H
    Clin Respir J; 2024 May; 18(5):e13749. PubMed ID: 38685745
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4239.